The NIH has concluded that senior researcher Dr. Thomas Walsh engaged in "serious misconduct" by failing to report more than $100,000 in outside income from unauthorized and unreported contracts with drug companies. A probe found that he accepted money from 25 companies, some of which owned the drugs he was studying. Report